Renoprotective Potential of Nateglinide in an Acute Kidney Injury Model
International Journal of Molecular Sciences · 26.03.2026 · 27 (7) · 3021
DOI: 10.3390/ijms27073021 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.03.2026. Verfasst von Senanur Ilıkça und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey. Hauptthemen laut MEDLINE: Acute Kidney Injury, Nateglinide, Reperfusion Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inonu University, Scientific Research Projects Unit of Inonu University, open-access publication.
Abstract (Originalsprache)
Nateglinide (Nat) is an oral antidiabetic agent of the meglitinide class that has been reported to exert protective effects beyond glycemic control, particularly against oxidative stress and inflammation. Since oxidative stress and inflammation play a key role in the pathogenesis of acute kidney injury (AKI), especially following ischemia/reperfusion (I/R), this study aimed to evaluate the potential renoprotective effects of Nat in a rat model of I/R-induced AKI. Forty male Sprague Dawley rats were randomly divided into four groups (n = 10): Control, I/R, I/R + Nat (50 mg/kg), and I/R + Nat (100 mg/kg). Bilateral renal ischemia was induced by clamping renal arteries for 45 min, followed by 24 h of reperfusion. Nat was administered orally 1 h before ischemia. Renal levels of superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), and thiobarbituric acid reactive substances (TBARSs) were assessed. Serum blood urea nitrogen (BUN), creatinine, tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) were also measured, and histopathological analyses were performed. Nat significantly increased renal antioxidant parameters and reduced TBARS levels. Moreover, Nat markedly decreased serum BUN, creatinine, TNF-α, and IL-1β levels compared with the I/R group (p < 0.05). Histopathology confirmed attenuated renal damage in Nat-treated groups (p < 0.0001). These results indicate that Nat confers significant renoprotection against renal I/R injury via suppression of oxidative stress and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.
- Department of Veterinary Medicine, School of Health Services, Osmaniye Korkut Ata University, 80000 Osmaniye, Turkey.
- Department of Histology and Embryology, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.
Förderung
- Inonu University
- Scientific Research Projects Unit of Inonu University
- open-access publication
Zitieren
APA
Ilıkça, S., Öz, S., Şekerci, G., Taşlıdere, A., & Tekin, S. (2026). Renoprotective Potential of Nateglinide in an Acute Kidney Injury Model. International Journal of Molecular Sciences, 27(7), 3021. https://doi.org/10.3390/ijms27073021
Vancouver
Ilıkça S, Öz S, Şekerci G, Taşlıdere A, Tekin S. Renoprotective Potential of Nateglinide in an Acute Kidney Injury Model. International Journal of Molecular Sciences. 2026;27(7):3021. doi:10.3390/ijms27073021
BibTeX
@article{Ilka2026,
author = {Ilıkça, Senanur and Öz, Samet and Şekerci, Güldeniz and Taşlıdere, Aslı and Tekin, Suat},
title = {Renoprotective Potential of Nateglinide in an Acute Kidney Injury Model},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3021},
doi = {10.3390/ijms27073021}
}
EUVIMED